Millennium Management LLC Invests $573,000 in Viemed Healthcare, Inc. (NASDAQ:VMD)

Millennium Management LLC purchased a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 71,489 shares of the company's stock, valued at approximately $573,000. Millennium Management LLC owned about 0.18% of Viemed Healthcare as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Lazard Asset Management LLC grew its stake in Viemed Healthcare by 34.9% in the 4th quarter. Lazard Asset Management LLC now owns 43,598 shares of the company's stock valued at $349,000 after buying an additional 11,273 shares during the last quarter. Expect Equity LLC acquired a new position in Viemed Healthcare in the 4th quarter valued at $1,369,000. Deutsche Bank AG grew its stake in Viemed Healthcare by 2,891.5% in the 4th quarter. Deutsche Bank AG now owns 23,214 shares of the company's stock valued at $186,000 after buying an additional 22,438 shares during the last quarter. Divisadero Street Capital Management LP grew its stake in Viemed Healthcare by 84.8% in the 4th quarter. Divisadero Street Capital Management LP now owns 646,273 shares of the company's stock valued at $5,183,000 after buying an additional 296,481 shares during the last quarter. Finally, Corton Capital Inc. acquired a new position in Viemed Healthcare in the 4th quarter valued at $82,000. Institutional investors and hedge funds own 74.24% of the company's stock.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $6.72 on Monday. Viemed Healthcare, Inc. has a 1 year low of $6.14 and a 1 year high of $9.81. The firm's fifty day simple moving average is $6.76 and its 200 day simple moving average is $7.59. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $265.60 million, a PE ratio of 24.89 and a beta of 1.38.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The business had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.